The following is a summary of “Risk factors for renal insufficiency and survival implications after radical nephrectomy and ...

Tactile Systems Technology (NASDAQ:TCMD – Get Free Report) is projected to release its earnings data after the market closes on Tuesday, February 18th. Analysts expect Tactile Systems Technology to ...

Take steps to improve blood flow to legs and help prevent venous conditions such as varicose and spider veins. Suggestions ...

The company said its EscharEx treatment had previously demonstrated its ability to effectively and rapidly remove damaged or ...

Phase III trial to assess the efficacy and safety of EscharEx® for debridement and facilitation of active wound closure Interim analysis planned after 65% of patients complete treatment, expected in ...

Phase III trial to assess the efficacy and safety of EscharEx® for debridement and facilitation of active wound closureInterim analysis planned ...